Sign in to view content

Prophylactic Ranibizumab for Exudative AMD in Vulnerable Eyes With Nonexudative AMD Trial (PREVENT) A Prospective Controlled Clinical Trial

Maziar Lalezary, MD

Video
Published 2018

Related

Peripheral Findings in Macular Telangiectasis Type 2
Stavros N Moysidis, M.D.
Annual Meeting Talks
2018
Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: Phase 2 LUNA Study Update
Glenn C. Yiu, MD, PhD
Updates from the Field
2025
Clinical Feasibility of Ultra-rapid, Non-pharmacologic Anesthesia for Intravitreal Injection in Patients Receiving Anti-VEGF Treatment
Cagri G Besirli, MD, PhD, FASRS
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more